Monoclonal Antibodies Targeting Amyloid ...

In the 25 years since its emergence in the US, West Nile virus has become the leading cause of domestic mosquito-borne disease. It causes approximately 1300 neuroinvasive disease cases and 130 deaths annually in the US. Coauthor Carolyn Gould, MD, of the CDC joins JAMA Senior Edi ... Show More

Worldwide, 1 in 3 women and 1 in 5 men older than 50 years experience osteoporotic fractures in their lifetime. Author Suzanne N. Morin, MD, MSc, of McGill University and JAMA Deputy Editor Mary M. McDermott, MD, discuss the diagnosis and management of osteoporosis. Related Conte ... Show More

Which tests can be used to diagnose type 2 diabetes? When should injectable medications for type 2 diabetes be started? These are just some of the questions clinicians may have when diagnosing and treating type 2 diabetes in adults. Author Rita Kalyani, MD, MHS, of Johns Hopkins ... Show More

Last year, researchers announced that the Alzheimer’s drug lecanemab lowered the amount of amyloid protein plaques associated with the disease in the brains of participants in a clinical trial, and slowed their cognitive decline.Now, researchers are looking to drug combinations, ... Show More

Amanda Grant Smith is a geriatric psychiatrist with decades of experience treating patients with dementia and Alzheimer's disease. In this episode, Amanda shares how she developed a passion for geriatric psychiatry as a means to support dementia patients. She explains how to reco ... Show More

Beau Ances (Washington University in St Louis, MO, USA) discusses recent research on amyloid biomarkers in people with genetic forms of Alzheimer’s disease; his Article is published in the January issue of The Lancet Neurology.  

Alzheimer’s disease is a devastating neurodegenerative condition that affects the entire family. As psychiatrists and psychologists, we often support these patients and their families throughout this entire disease process. With the recent and controversial FDA approval of aducan ... Show More

Following National Alzheimer’s Disease Awareness Month, the CDC shares what physicians and patients need to know about the disease. Lisa McGuire, PhD, lead epidemiologist at the CDC, discusses the importance of catching Alzheimer’s early, its risk factors and barriers to make Alz ... Show More

Do you know all there is to know beyond amyloid and tau in Alzheimer's disease? Credit available for this activity expires: 02/15/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000023?ecd=bdc_podcast_libsyn_mscpedu 

You are not powerless in the face of this staggeringly common disease. This episode features audio from Pesticides (DDT) and Alzheimer’s Disease, How to Prevent Alzheimer’s with Diet, and Reducing Glycotoxin Intake to Prevent Alzheimer’s. Visit the video pages for all sources and ... Show More

In this Medical News podcast, Rita Rubin interviews retired neurologist Daniel Gibbs, MD, about his efforts to lessen the stigma surrounding Alzheimer disease, which he was diagnosed with 5 years ago. Related Content: Neurologist Faces His Alzheimer Diagnosis Determined to Lessen ... Show More

View the Show Notes Page for This Episode Become a Member to Receive Exclusive Content Sign Up to Receive Peter’s Weekly Newsletter Dena Dubal is a physician-scientist and professor of neurology at UCSF whose work focuses on mechanisms of longevity and brain resilience. In this e ... Show More

A study yet to be peer-reviewed has assessed the evidence on treating COVID-19 with antibody infusions—particularly monoclonal antibodies. It has found that in the early days of the pandemic doses were too high—but things are different with Omicron and its variants, because the a ... Show More